OP-1 LONG-TERM EFFICACY AND SAFETY OF OPEN-LABEL SELADELPAR TREATMENT IN PATIENTS WITH PRIMARY BILIARY CHOLANGITIS: INTERIM 2-YEAR RESULTS FROM THE ASSURE STUDY
Palak J. Trivedi1, Cynthia Levy2, Kris V. Kowdley3, Stuart C. Gordon4, Christopher L. Bowlus5, Maria Carlota Londoño Hurtado6, Gideon M. Hirschfield7, Aliya F. Gulamhusien3, Eric J. Lawitz8, Alejandra Villamil9, Alma Ladron de Guevara Cetina10, Marlyn J. Mayo11, Ziad H. Younes12, Oren Shibolet13, Kidist K. Yimam14, Daniel S. Pratt15, Jeong Heo16, Ulrike Morgera17, Pietro Andreone18, Andreas E. Kremer19..., Christophe Corpechot20, Aparna Goel21, Adam Peyton22, Hany Elbeshbeshy23, Daria B. Crittenden24, Carrie Heusner24, Sarah Proehl24, Shuqiong Zhou24, Charles A. McWherter24Ver más
1 University of Birmingham, Birmingham, Reino Unido (RU)
2 University of Miami, Miami, Estados Unidos (EEUU)
3 Liver Institute Northwest, Seattle, Estados Unidos (EEUU)
4 Division of Gastroenterology and Hepatology, Henry Ford Health, Detroit, Estados Unidos (EEUU)
5 Department of Medicine, Division of Gastroenterology and Hepatology, University of California Davis Health, Sacramento, Estados Unidos (EEUU)
6 The Liver Unit, Hospital Clínic Barcelona, Fundació de Recerca Clínic Barcelona-Institut d'Investigacions Biomèdiques August Pi i Sunyer, CIBEREHD, European Reference Network on Hepatological Diseases, Barcelona, España
7 Division of Gastroenterology and Hepatology, Toronto Centre for Liver Disease, University of Toronto, Toronto, Canadá
8 The Texas Liver Institute, University of Texas Health, San Antonio, Estados Unidos (EEUU)
9 Hepatic Autoimmunity Unit, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina
10 Centro de Investigación y Gastroenterología, Mexico City, México
11 Division of Digestive and Liver Diseases, Department of Internal Medicine, University of Texas Southwestern, Dallas, Estados Unidos (EEUU)
12 GastroOne, Germantown, Estados Unidos (EEUU)
13 The Research Center for Digestive Tract and Liver Diseases, Tel Aviv Sourasky Medical Center and Faculty of Medical and Health Sciences, Tel Aviv University, Tel Aviv, Israel
14 Department of Hepatology and Liver Transplantation, California Pacific Medical Center, San Francisco, Estados Unidos (EEUU)
15 Massachusetts General Hospital, Harvard Medical School, Boston, Estados Unidos (EEUU)
16 Department of Internal Medicine, Pusan National University and Biomedical Research Institute, Busan, Corea (del Sur)
17 Outpatient Clinic, Charité, Universitätsmedizin Berlin, Berlin, Alemania
18 University of Modena and Reggio Emilia, Internal Medicine, Baggiovara Hospital, Modena, Italia
19 University Hospital Zurich, Zurich, Suiza
20 Reference Centre for Inflammatory Biliary Diseases and Auto-Immune Hepatitis, Saint-Antoine Hospital, Paris, Francia
21 Department of Medicine, Stanford University, Palo Alto, Estados Unidos (EEUU)
22 Miami Veterans Affairs Healthcare System, Miami, Estados Unidos (EEUU)
23 Department of Internal Medicine, Saint Louis University School of Medicine, St. Louis, Estados Unidos (EEUU)
24 CymaBay, a Gilead Sciences Company, Fremont, Estados Unidos (EEUU)
Ver másRead
653
Timeswas read the article
176
Total PDF
477
Total HTML
| Year/Month | Html | Total | |
|---|---|---|---|
| 2025 12 | 9 | 5 | 14 |
| 2025 11 | 97 | 43 | 140 |
| 2025 10 | 35 | 19 | 54 |
| 2025 9 | 38 | 22 | 60 |
| 2025 8 | 34 | 26 | 60 |
| 2025 7 | 50 | 11 | 61 |
| 2025 6 | 40 | 6 | 46 |
| 2025 5 | 38 | 5 | 43 |
| 2025 4 | 23 | 6 | 29 |
| 2025 3 | 24 | 5 | 29 |
| 2025 2 | 15 | 6 | 21 |
| 2025 1 | 41 | 3 | 44 |
| 2024 12 | 33 | 19 | 52 |
Show all
